Geneos Wealth Management’s Vanguard S&P Mid-Cap 400 Growth ETF IVOG Stock Holding History
Bought
Maintained
Sold
Other funds holding IVOG
RJFSA
SCM
LWM
KAS
Geneos Wealth Management's IVOG Position: Q1 2023 in Review
Geneos Wealth Management sold out of Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) in Q1 2023, closing a stake of 20 shares — an estimated $1.69K sold.
Geneos Wealth Management first reported a position in IVOG in Q4 2020 and held it in 9 quarters. The position peaked at $1.67M in Q4 2021. 98 funds tracked by Wall St. Rank hold IVOG as of Q1 2023.
- Geneos Wealth Management reported no remaining Vanguard S&P Mid-Cap 400 Growth ETF position as of Q1 2023 after selling out during the quarter.
- Geneos Wealth Management sold 20 Vanguard S&P Mid-Cap 400 Growth ETF shares in Q1 2023, an estimated $1.69K.
- Geneos Wealth Management first reported a position in Vanguard S&P Mid-Cap 400 Growth ETF in Q4 2020 and held it in 9 quarters.
- Geneos Wealth Management's Vanguard S&P Mid-Cap 400 Growth ETF position peaked at $1.67M in Q4 2021.
- 98 funds tracked by Wall St. Rank held Vanguard S&P Mid-Cap 400 Growth ETF as of Q1 2023.
Based on Geneos Wealth Management's 13F filing for Q1 2023, filed 25 Apr 2023.